State Street SPDR S&P Biotech ETF
Limited financial coverage for XBI.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
SPDR Series Trust - State Street SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States.
- IPO
- 2006
- HQ
- Boston, MA, US
Get TickerSpark's AI analysis on XBI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $8.67B
- Div Yield
- 0.34%
- 52W High
- $169.68
- 52W Low
- $88.60
- 50D MA
- $153.30
- 200D MA
- $132.68
- Beta
- 1.10
- RSI (14)
- 63
- Avg Volume
- 9.00M
No earnings-call transcripts are available for XBI yet.
- Free Float
- 0.0%
- Shares Outstanding
- 52.29M
- Float Shares
- 0
of shares held by institutions
901 13F filers
Congressional trading
Senate and House stock disclosures for XBI, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Tommy TubervilleSenate · AL | Buy | May 8, 24 | Filing → |
| Tommy TubervilleSenate · AL | Buy | May 8, 24 | Filing → |
| Tommy TubervilleSenate · AL | Buy | May 8, 24 | Filing → |
| Tommy TubervilleSenate · AL | Buy | May 8, 24 | Filing → |
| James InhofeSenate · OK | Sell | Sep 30, 19 | Filing → |
| James InhofeSenate · OK | Buy | Dec 31, 18 | Filing → |
| John ReedSenate · RI | Sell | Mar 9, 18 | Filing → |
| John ReedSenate · RI | Buy | Jun 19, 17 | Filing → |
| John ReedSenate · RI | Buy | Mar 6, 17 | Filing → |
| John ReedSenate · RI | Buy | Mar 6, 17 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Bnp Paribas Arbitrage, Snc | 16.78M | ▼ 4.38M |
| Goldman Sachs Group Inc | 15.11M | ▲ 1.39M |
| Citigroup Inc | 11.61M | ▲ 949.48K |
| Morgan Stanley | 10.83M | ▼ 1.50M |
| Bank Of America Corp | 10.57M | ▼ 3.95M |
| Healthcare Of Ontario Pension Plan Trust Fund | 9.34M | ▼ 404.00K |
| Wells Fargo & Company/Mn | 3.50M | ▲ 757.87K |
| Ubs Group AG | 3.31M | ▼ 237.73K |
| Barclays PLC | 2.82M | ▼ 16.22K |
| Jefferies Financial Group Inc. | 2.14M | ▼ 174.72K |
| Jpmorgan Chase & Co | 1.81M | ▼ 4.43M |
| Canada Pension Plan Investment Board | 1.76M | 0 |
Held by 9 ETFs
Biggest fund positions in XBI by dollar value.
Our XBI coverage
Recent articles, reports, and earnings notes.
Want a deeper read on XBI?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
XBI: Biotech's Breakthrough Moment Happend This Week (Upgrade)
seekingalpha.com · Aug 20
IHE vs. XBI: Pharma Stability or Biotech Growth -- Which Healthcare ETF Is the Better Buy?
fool.com · Aug 20
XBI vs. FBT: Broad Biotech Exposure or Concentrated Bets?
fool.com · Aug 19
Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI?
fool.com · Aug 18
Are Biotech Stocks The 'Comeback Kid' Of 2026? I Say Yes
seekingalpha.com · Aug 16
Bay Colony Advisory Group Inc d b a Bay Colony Advisors Invests $793,000 in SPDR S&P Biotech ETF $XBI
defenseworld.net · Aug 12
iShares Global Healthcare ETF vs State Street SPDR Biotech ETF. Which Healthcare-Focused Fund Will Bring You Profits in 2026 and Beyond?
fool.com · Aug 8
These New Drugs Could Fuel Fresh Highs for Biotech and Pharma Stocks
barrons.com · Aug 7
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.